{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:07:18Z","timestamp":1794748038461,"version":"4.9.1"},"reference-count":76,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Metabolic reprogramming is a hallmark of cancer and is essential for sustaining leukemogenesis. In acute myeloid leukemia (AML), a high dependency on oxidative phosphorylation (OXPHOS) is often linked to poor outcomes, and its inhibition has shown to be highly effective. However, most OXPHOS inhibitors are not clinically translatable because of significant side effects. Thus, repurposing safe US Food and Drug Administration\u2013approved drugs that can target OXPHOS is of great interest. Here, we evaluated metformin, an antidiabetic drug that inhibits OXPHOS, in a genetically diverse panel of primary AML samples to identify metabolic profiles that can be used to predict treatment susceptibility. Using label-free quantitative proteome analysis on sorted CD34+\/CD117+ AML cells, we performed single-sample gene set enrichment analysis focused on metabolic terms and correlated enrichment scores with metformin sensitivity, followed by functional studies. Ex vivo treatment of AML samples with metformin showed a significant increase in reactive oxygen species levels and ferroptosis induction, especially in samples with disturbed lipid metabolism, such as IDH2- and FLT3-mutant AMLs. In IDH2-mutant cells, cotreatment with palmitate, a saturated fatty acid (FA), increased metformin sensitivity, which could be rescued by CD36 knockdown, rendering these cells more resistant to treatment. Lipidomic analysis revealed profound alterations upon metformin treatment, including increased production of triglycerides and polyunsaturated FAs, further supporting a metabolic shift. We observed upregulation of genes related to lipid droplet formation, including DGAT1, a key enzyme in this process. DGAT1 inhibition was strongly synergistic with metformin, whereas iron chelators acted antagonistically. Our results underscore the potential of leveraging metabolic vulnerabilities in AML to identify more effective and personalized therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016155","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T19:52:26Z","timestamp":1761940346000},"page":"733-747","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Metformin induces ferroptosis associated with lipidomic remodeling in AML"],"prefix":"10.1182","volume":"10","author":[{"given":"Dominique","family":"Sternadt","sequence":"first","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-4311","authenticated-orcid":false,"given":"Diego A.","family":"Pereira-Martins","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"},{"name":"2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0048-4100","authenticated-orcid":false,"given":"Prodromos","family":"Chatzikyriakou","sequence":"additional","affiliation":[{"name":"2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Albuquerque-Sim\u00f5es","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"},{"name":"3Hematology Division, Center for Cell Based Therapy, University of S\u00e3o Paulo, Ribeirao Preto, Brazil"},{"name":"4Hematology Division, Faculty of Medicine, University of S\u00e3o Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7735-7804","authenticated-orcid":false,"given":"Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"5Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases, Institute for Metabolomics in Ageing, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5298-9592","authenticated-orcid":false,"given":"Douglas R. A.","family":"Silveira","sequence":"additional","affiliation":[{"name":"2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus T. J.","family":"Wierenga","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Weinh\u00e4user","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"},{"name":"2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-5333","authenticated-orcid":false,"given":"Shanna M.","family":"Hogeling","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-8028","authenticated-orcid":false,"given":"Lieve L.","family":"Oudejans","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4232-9755","authenticated-orcid":false,"given":"Pilar","family":"Casares Alaez","sequence":"additional","affiliation":[{"name":"2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-2032","authenticated-orcid":false,"given":"Jean-Emmanuel","family":"Sarry","sequence":"additional","affiliation":[{"name":"6Metabolism and Drug Resistance in Acute Myeloid Leukemia, Centre de Recherches en Canc\u00e9rologie de Toulouse, Universit\u00e9 de Toulouse, INSERM, Centre national de la recherche scientifique, Toulouse, France"},{"name":"7Equipe de Recherche Lab\u00e9lis\u00e9e Ligue Nationale Contre le Cancer en 2023, Toulouse, France"},{"name":"8Laboratoire d\u2019Excellence Toulouse Cancer, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Frezza","sequence":"additional","affiliation":[{"name":"5Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases, Institute for Metabolomics in Ageing, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"},{"name":"9Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Disease, Faculty of Mathematics and Natural Sciences, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerwin A.","family":"Huls","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-5761","authenticated-orcid":false,"given":"Lynn","family":"Quek","sequence":"additional","affiliation":[{"name":"2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-8555","authenticated-orcid":false,"given":"Jan Jacob","family":"Schuringa","sequence":"additional","affiliation":[{"name":"1Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"23","key":"2026021015532006500_bib1","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"2026021015532006500_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2018.08.014","article-title":"Prospective isolation and characterization of genetically and functionally distinct AML subclones","volume":"34","author":"de Boer","year":"2018","journal-title":"Cancer Cell"},{"issue":"7834","key":"2026021015532006500_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"1","key":"2026021015532006500_bib4","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"2026021015532006500_bib5","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in Acute Myeloid Leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"2026021015532006500_bib6","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1016\/S2352-3026(23)00159-X","article-title":"Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts","volume":"10","author":"Shallis","year":"2023","journal-title":"Lancet Haematol"},{"issue":"12","key":"2026021015532006500_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2026021015532006500_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"12","key":"2026021015532006500_bib9","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"2026021015532006500_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-022-28737-3","article-title":"The glycolytic gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"2026021015532006500_bib11","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/s41467-022-29639-0","article-title":"Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"2026021015532006500_bib12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/2159-8290.CD-22-0411","article-title":"C\/EBP\u03b1 confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress\u2013induced ferroptosis in FLT3-mutant leukemia","volume":"13","author":"Sabatier","year":"2023","journal-title":"Cancer Discov"},{"issue":"1","key":"2026021015532006500_bib13","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41598-018-23863-9","article-title":"Distinct metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood acute myeloid leukemia","volume":"8","author":"Stockard","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"2026021015532006500_bib14","doi-asserted-by":"crossref","first-page":"E393","DOI":"10.3324\/haematol.2018.206821","article-title":"Adult patients with de novo acute myeloid leukemia show a functional deregulation of redox balance at diagnosis which is correlated with molecular subtypes and overall survival","volume":"104","author":"Mondet","year":"2019","journal-title":"Haematologica"},{"issue":"1-2","key":"2026021015532006500_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"issue":"2","key":"2026021015532006500_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/2159-8290.CD-21-0218","article-title":"Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability","volume":"13","author":"Thomas","year":"2023","journal-title":"Cancer Discov"},{"issue":"2","key":"2026021015532006500_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2643-3230.BCD-23-0195","article-title":"IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation","volume":"5","author":"Landberg","year":"2024","journal-title":"Blood Cancer Discov"},{"issue":"5","key":"2026021015532006500_bib18","doi-asserted-by":"crossref","first-page":"e20200924","DOI":"10.1084\/jem.20200924","article-title":"Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia","volume":"218","author":"Stuani","year":"2021","journal-title":"J Exp Med"},{"issue":"7","key":"2026021015532006500_bib19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"7","key":"2026021015532006500_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"2026021015532006500_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat Med"},{"issue":"6630","key":"2026021015532006500_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1126\/science.ade3332","article-title":"Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides","volume":"379","author":"Bridges","year":"2023","journal-title":"Science"},{"issue":"5","key":"2026021015532006500_bib23","first-page":"302","article-title":"Metformin: from diabetes to cancer\u2014unveiling molecular mechanisms and therapeutic strategies","volume":"13","author":"Amengual-Cladera","year":"2024","journal-title":"Biology (Basel)"},{"issue":"6","key":"2026021015532006500_bib24","first-page":"1278","article-title":"Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia","volume":"110","author":"Hogeling","year":"2025","journal-title":"Haematologica"},{"issue":"43","key":"2026021015532006500_bib25","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2026021015532006500_bib26","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.3390\/ijms19113325","article-title":"Stable isotope labeling highlights enhanced fatty acid and lipid metabolism in human acute myeloid leukemia","volume":"19","author":"Stuani","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2026021015532006500_bib27","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1158\/0008-5472.CAN-22-3682","article-title":"CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia","volume":"83","author":"Farge","year":"2023","journal-title":"Cancer Res"},{"issue":"7","key":"2026021015532006500_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"4","key":"2026021015532006500_bib29","doi-asserted-by":"crossref","first-page":"100864","DOI":"10.1016\/j.xpro.2021.100864","article-title":"CombiFlow: flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones","volume":"2","author":"Houtsma","year":"2021","journal-title":"STAR Protoc"},{"issue":"1","key":"2026021015532006500_bib30","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/s41467-022-30223-9","article-title":"Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia","volume":"13","author":"Bassal","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"2026021015532006500_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2026021015532006500_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-019-0206-y","article-title":"HIF1\/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem\/progenitor cells","volume":"7","author":"Wierenga","year":"2019","journal-title":"Cancer Metab"},{"issue":"1","key":"2026021015532006500_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2026021015532006500_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2026021015532006500_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2026021015532006500_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"4","key":"2026021015532006500_bib37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cmet.2024.01.006","article-title":"PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression","volume":"36","author":"Yang","year":"2024","journal-title":"Cell Metab"},{"issue":"4","key":"2026021015532006500_bib38","doi-asserted-by":"crossref","first-page":"112054","DOI":"10.1016\/j.isci.2025.112054","article-title":"BMAL1-depletion remodels ceramide metabolism to regulate ferroptosis and sorafenib chemosensitivity in acute myeloid leukemia","volume":"28","author":"Zheng","year":"2025","journal-title":"iScience"},{"key":"2026021015532006500_bib39","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286228","article-title":"The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemia","author":"Zhao","year":"10  2025","journal-title":"Haematologica"},{"issue":"1","key":"2026021015532006500_bib40","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1038\/s41467-025-63813-4","article-title":"Cardiolipin dynamics promote membrane remodeling by mitochondrial OPA1","volume":"16","author":"Thatavarthy","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"2026021015532006500_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2026021015532006500_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbabio.2013.10.006","article-title":"Functional role of cardiolipin in mitochondrial bioenergetics","volume":"1837","author":"Paradies","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2026021015532006500_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tcb.2017.08.011","article-title":"Phosphatidic Acid and Cardiolipin Coordinate Mitochondrial Dynamics","volume":"28","author":"Kameoka","year":"2018","journal-title":"Trends Cell Biol"},{"issue":"12","key":"2026021015532006500_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrm3699","article-title":"The biophysics and cell biology of lipid droplets","volume":"14","author":"Thiam","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026021015532006500_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","article-title":"Lipid droplets and cellular lipid metabolism","volume":"81","author":"Walther","year":"2012","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"2026021015532006500_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein Cell"},{"issue":"1","key":"2026021015532006500_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12967-024-05084-z","article-title":"The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications. J Transl Med","volume":"22","author":"Deng","year":"2024","journal-title":"J Transl Med"},{"issue":"1","key":"2026021015532006500_bib48","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/s41467-020-17882-2","article-title":"Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites","volume":"11","author":"Bosc","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"2026021015532006500_bib49","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/biomedicines11123186","article-title":"An overview on lipid droplets accumulation as novel target for acute myeloid leukemia therapy","volume":"11","author":"Nistic\u00f2","year":"2023","journal-title":"Biomedicines"},{"issue":"1-2","key":"2026021015532006500_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","article-title":"Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration","volume":"160","author":"Liu","year":"2015","journal-title":"Cell"},{"issue":"1","key":"2026021015532006500_bib51","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1038\/s41598-019-48059-7","article-title":"Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis","volume":"9","author":"Chaves-Filho","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"2026021015532006500_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2026021015532006500_bib53","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2013.107","article-title":"Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells","volume":"27","author":"Scotland","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"2026021015532006500_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"21","key":"2026021015532006500_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood.V120.21.206.206","article-title":"Bcl-2 inhibitor ABT-263 targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"120","author":"Lagadinou","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2026021015532006500_bib56","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/cbf.3869","article-title":"Targeted single-cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis-resistant state in hematologic malignancies","volume":"41","author":"Shen","year":"2023","journal-title":"Cell Biochem Funct"},{"issue":"9","key":"2026021015532006500_bib57","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/1541-7786.MCR-21-1069","article-title":"Monounsaturated fatty acids: key regulators of cell viability and intracellular signaling in cancer","volume":"20","author":"Scott","year":"2022","journal-title":"Mol Cancer Res"},{"issue":"11","key":"2026021015532006500_bib58","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41375-024-02390-9","article-title":"Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation","volume":"38","author":"Dembitz","year":"2024","journal-title":"Leukemia"},{"issue":"4","key":"2026021015532006500_bib59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","article-title":"Mitochondrial regulation of GPX4 inhibition\u2013mediated ferroptosis in acute myeloid leukemia","volume":"38","author":"Akiyama","year":"2024","journal-title":"Leukemia"},{"issue":"10","key":"2026021015532006500_bib60","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.molcel.2024.04.009","article-title":"Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers","volume":"84","author":"Mao","year":"2024","journal-title":"Mol Cell"},{"issue":"2","key":"2026021015532006500_bib61","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol Cell"},{"issue":"1","key":"2026021015532006500_bib62","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41419-025-07510-6","article-title":"Inhibition of mitochondrial complex I induces mitochondrial ferroptosis by regulating CoQH2 levels in cancer","volume":"16","author":"Deng","year":"2025","journal-title":"Cell Death Dis"},{"issue":"1","key":"2026021015532006500_bib63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11033-024-09662-8","article-title":"Metformin-induced oxidative stress inhibits LNCaP prostate cancer cell survival","volume":"51","author":"Dixon","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2026021015532006500_bib64","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1038\/s41598-021-93270-0","article-title":"Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells","volume":"11","author":"Warkad","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"2026021015532006500_bib65","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2011.06.033","article-title":"Cross talk between mitochondria and NADPH oxidases","volume":"51","author":"Dikalov","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"2026021015532006500_bib66","doi-asserted-by":"crossref","first-page":"670076","DOI":"10.3389\/fphar.2021.670076","article-title":"Coordinated contribution of NADPH oxidase- and mitochondria-derived reactive oxygen species in metabolic syndrome and its implication in renal dysfunction","volume":"12","author":"Lee","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"2026021015532006500_bib67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.freeradbiomed.2007.03.028","article-title":"Regulation of nox and duox enzymatic activity and expression","volume":"43","author":"Lambeth","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"2026021015532006500_bib68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrc3339","article-title":"Aiding and abetting roles of NOX oxidases in cellular transformation","volume":"12","author":"Block","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2026021015532006500_bib69","doi-asserted-by":"crossref","first-page":"101645","DOI":"10.1016\/j.xcrm.2024.101645","article-title":"Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"2026021015532006500_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41419-017-0256-4","article-title":"Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms","volume":"9","author":"Machado-Neto","year":"2018","journal-title":"Cell Death Dis"},{"issue":"8067","key":"2026021015532006500_bib71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-025-08871-w","article-title":"Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs","volume":"642","author":"Hosseini","year":"2025","journal-title":"Nature"},{"issue":"5","key":"2026021015532006500_bib72","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bjh.18968","article-title":"Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress\u2014CHOP pathway","volume":"202","author":"Hua","year":"2023","journal-title":"Br J Haematol"},{"issue":"1","key":"2026021015532006500_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12944-015-0006-5","article-title":"Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome","volume":"14","author":"Meyers","year":"2015","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2026021015532006500_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/dom.12002","article-title":"Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study","volume":"15","author":"Denison","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2026021015532006500_bib75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/dom.12221","article-title":"Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial","volume":"16","author":"Denison","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2026021015532006500_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/733\/2501720\/blooda_adv-2025-016155-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/733\/2501720\/blooda_adv-2025-016155-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:53:39Z","timestamp":1770756819000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/3\/733\/548006\/Metformin-induces-ferroptosis-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016155","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,10]]},"published":{"date-parts":[[2026,1,30]]}}}